Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

American Journal of Medicine

Volumn 118, Issue 12, 2005, Pages 1331-1339

  McNaughton Collins, Mary ^a   Barry, Michael J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Benign prostatic hyperplasia; Diagnosis; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DOXAZOSIN; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN; SILDENAFIL;

ALTERNATIVE MEDICINE; ASTHENIA; BLADDER FILLING; BLADDER OBSTRUCTION; CHEMOPROPHYLAXIS; CREATININE BLOOD LEVEL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIZZINESS; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LABORATORY TEST; LIBIDO DISORDER; MICTURITION; MICTURITION CYSTOURETHROGRAPHY; MICTURITION DISORDER; MINIMALLY INVASIVE SURGERY; NOSE CONGESTION; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PATIENT INFORMATION; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; REVIEW; RISK ASSESSMENT; RISK FACTOR; URINALYSIS; URINARY FREQUENCY; URINE CYTOLOGY; URINE FLOW RATE; URODYNAMICS;

ADRENERGIC ALPHA-ANTAGONISTS; DISEASE PROGRESSION; ENZYME INHIBITORS; HUMANS; INCIDENCE; MALE; PATIENT CARE PLANNING; PHYSICAL EXAMINATION; PRACTICE GUIDELINES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; URINALYSIS; URINATION DISORDERS; URODYNAMICS;

EID: 29244467960     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.12.033     Document Type: Review

References (60)

1. S.J. Berry, D.S. Coffey, P.C. Walsh, L.L. Ewing The development of human benign prostatic hyperplasia with age J Urol 132 1984 474 479
2. N. Masumori, T. Tsukamoto, Y. Kumamoto Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men results of community based studies in 2 countries J Urol 155 1996 1324 1327
3. J. Bosch, W. Hop, A. Niemer Parameters of prostate volume and shape in a community based population of men 55 to 74 years old J Urol 152 1994 1501 1505
4. C. Girman, L. Panser, C. Chute Natural history of prostatism urinary flow rates in a community-based study J Urol 150 1993 887 892
5. J. Bosch, W.C. Hop, W.J. Kirkels, F.H. Schroder Natural history of benign prostatic hyperplasia appropriate case definition and estimation of its prevalence in the community Urology 46 1995 34 40
6. S.J. Jacobsen, C.J. Girman, H.A. Guess Natural history of prostatism longitudinal changes in voiding symptoms in community dwelling men J Urol 155 1996 595 600
7. S. Jacobsen, D. Jacobson, C. Girman Natural history of prostatism risk factors for acute urinary retention J Urol 158 1997 481 487
8. J. Meigs, M. Barry, E. Giovannucci Incidence rates and risk factors for acute urinary retention the health professionals followup study J Urol 162 1999 376 382
9. J.D. McConnell, R. Bruskewitz, P. Walsh Finasteride Long-Term Efficacy and Safety Study Group The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia N Engl J Med 338 1998 557 563
10. J.D. McConnell, C.G. Roehrborn, O.M. Bautista The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387 2398
11. C.G. Roehrborn, R. Bruskewitz, J.C. Nickel Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia J Urol 171 2004 1194 1198
12. C. Roehrborn, R. Bruskewitz, G. Nickel Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes Eur Urol 37 2000 528 536
13. C.G. Roehrborn, M. Malice, T.J. Cook, C.J. Girman Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH a comprehensive analysis of the pooled placebo groups of several large clinical trials Urology 58 2001 210 216
14. J. Andersen, J. Nickel, V. Marshall Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia Urology 49 1997 839 845
15. J. Wasson, D. Reda, R. Bruskewitz A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia N Engl J Med 332 1995 75 79
16. M.J. Barry, F.J. Fowler, L. Bin The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists J Urol 157 1997 10 15
17. E.A. Platz, I. Kawachi, E.B. Rimm Race, ethnicity, and benign prostatic hyperplasia in the health professionals follow-up study J Urol 163 2000 490 495
18. A.W. Partin, W.F. Page, B.R. Lee Concordance rates for benign prostatic disease among twins suggest hereditary influence Urology 44 1994 646 650
19. M.G. Sanda, T.H. Beaty, R.E. Stutzman Genetic susceptibility of benign prostatic hyperplasia J Urol 152 1994 115 119
20. M.G. Sanda, C.B. Doehring, B.S. Binkowitz Clinical and biological characteristics of familial benign prostatic hyperplasia J Urol 157 1997 876 879
21. M. Cetinkaya, H. Cetinkaya, E. Ulusoy Effect of postnecrotic and alcoholic hepatic cirrhosis on development of benign prostatic hyperplasia Prostate 36 1998 80 84
22. E.A. Platz, I. Kawachi, E.B. Rimm Physical activity and benign prostatic hyperplasia Arch Intern Med 158 1998 2349 2356
23. J.B. Meigs, B. Mohr, M.J. Barry Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men J Clin Epidemiol 54 2001 935 944
24. P. Boyle, G. Liu, S. Jacobsen Epidemiology and natural history C. Chatelain L. Denis K. Foo Benign Prostatic Hyperplasia (5th International Consultation on BPH) 2001 Health Publication, Ltd Jersey, UK 19 68 (distributed by: Plymbridge Distributors, Ltd., Plymouth, UK);
25. J. McNeal Normal histology of the prostate Am J Surg Pathol 12 1988 619 633
26. P. Abrams New words for old lower urinary tract symptoms for "prostatism." BMJ 308 1994 929 930
27. C. Lee, A. Cockett, O. Cussenot Regulation of prostate growth C. Chatelain L. Denis K. Foo Benign Prostatic Hyperplasia (5th International Consultation on BPH) 2001 Health Publication, Ltd Jersey, UK 81 106 (distributed by: Plymbridge Distributors, Ltd., Plymouth, UK);
28. J.D. McConnell, M.J. Barry, R.C. Bruskewitz Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guideline, Number 8 1994 Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services Rockville, MD
29. American Urological Association Practice Guidelines Committee American Urological Association guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations J Urol. 170 2003 530 547
30. M.J. Barry, F.J. Fowler, M.P. O'Leary Measuring disease-specific health status in men with benign prostatic hyperplasia Med Care 33 1995 AS145 AS155
31. M.J. Barry, F.J. Fowler Jr, M.P. O'Leary The Measurement Committee of the American Urological Association The American Urological Association symptom index for benign prostatic hyperplasia J Urol 148 1992 1549 1557
32. M. Barry, J. Batista, J. Donovan Measuring the symptoms and health impact of benign prostatic hyperplasia and its treatments C. Chatelain L. Denis K. Foo Benign Prostatic Hyperplasia (5th International Consultation on BPH) 2001 Health Publication, Ltd Jersey, UK 203 225 (distributed by: Plymbridge Distributors, Ltd., Plymouth, UK);
33. C.R. Porter, J. Kim Low AUA symptom score independently predicts positive prostate needle biopsy results from a racially diverse series of 411 patients Urology 63 2004 90 94
34. M.H. Blanker, F.P.M.J. Groeneveld, S. Thomas Prostate cancer detection in older men with and without lower urinary tract symptoms a population-based study J Am Geriatr Soc 51 2003 1041 1042
35. J.M. Young, D.J. Muscatello, J.E. Ward Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence BJU Int 85 2000 1037 1048
36. P. Abrams, B. Klevmark Frequency volume charts an indispensable part of lower urinary symptom assessment Scand J Urol Nephrol 179 1996 47 53
37. D. Smith, W. Catalona Interexaminer variability of digital rectal examination in detecting prostate cancer Urology 45 1995 70 74
38. C. Roehrborn, C. Girman, T. Rhodes Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound Urology 49 1997 548 557
39. W. Catalona, J. Richie, F. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer results of a multicenter clinical trial of 6,630 men J Urol 151 1994 1283 1290
40. C. Roehrborn, P. Boyle, A. Gould, J. Waldstreicher Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia Urology 53 1999 581 589
41. C. Roehrborn, J. McConnell, M. Lieber Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia Urology 53 1999 473 480
42. C.G. Roehrborn, J. McConnell, J. Bonilla Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long term efficacy and safety study J Urol 163 2000 13 20
43. P. Abrams In support of pressure-flow studies for evaluating men with lower urinary tract symptoms Urology 44 1994 153 155
44. J. McConnell Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia Urology 44 1994 156 158
45. H. Lepor The pathophysiology of lower urinary tract symptoms in the ageing male population Br J Urol 81 Suppl 1 1998 29 33
46. H. Lepor, W.O. Williford, M.J. Barry Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response J Urol 160 1998 1358 1367
47. B. Djavan, M. Marberger A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction Eur Urol 36 1999 1 13
48. ALLHAT Collaborative Research Group Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) JAMA 283 2000 1967 1975
49. C.G. Roehrborn, P. Boyle, A.L. Gould, J. Waldstreicher Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia Urology 53 1999 581 589
50. C.G. Roehrborn, P. Boyle, J.C. Nichol Efficacy and safety of a dual inhibitor of 5-alpha reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia Urology 60 2002 434 441
51. G.L. Andriole, H.A. Guess, J.I. Epstein PLESS Study Group Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. Proscar Long-term Efficacy and Safety Study Urology 52 1998 195 201
52. I. Thompson, P. Goodman, C. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215 224
53. C.G. Roehrborn Prevention of prostate cancer with finasteride N Engl J Med 349 2003 1569 1572
54. H. Lepor, W.O. Williford, M.J. Barry Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia N Engl J Med 335 1996 533 539
55. T.J. Wilt, A. Ishani, G. Stark Saw palmetto extracts for treatment of benign prostatic hyperplasia a systematic review JAMA 280 1998 1604 1609
56. R. MacDonald, A. Ishani, I. Rutks, T. Wilt A systematic review of Cernilton for the treatment of benign prostatic hyperplasia BJU Int 85 1999 836 841
57. A. Ishani, R. MacDonald, D. Nelson Pygeum africanum for the treatment of patients with benign prostatic hyperplasia a systematic review and quantitative meta-analysis Am J Med 109 2000 654 664
58. T. Wilt, R. MacDonald, A. Ishani Beta-sitosterol for the treatment of benign prostatic hyperplasia a systematic review BJU Int 83 1999 976 983
59. J. Donovan, T. Peters, D. Neal A randomised trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement the CLASP study J Urol 164 2000 65 70
60. J. Wasson, T. Bubolz, G. Lu-Yao Transurethral resection of the prostate among Medicare beneficiaries 1984 to 1997 J Urol 164 2000 1212 1215